Madrigal Pharmaceuticals Inc (MDGL)
302.67
-12.48
(-3.96%)
USD |
NASDAQ |
Nov 14, 16:00
303.04
+0.37
(+0.12%)
After-Hours: 20:00
Madrigal Pharmaceuticals Cash from Investing (Quarterly): -202.39M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -202.39M |
| June 30, 2024 | -122.10M |
| March 31, 2024 | 98.05M |
| December 31, 2023 | -362.12M |
| September 30, 2023 | 50.20M |
| June 30, 2023 | -3.732M |
| March 31, 2023 | -186.86M |
| December 31, 2022 | 66.39M |
| September 30, 2022 | 65.14M |
| June 30, 2022 | 19.24M |
| March 31, 2022 | 55.93M |
| December 31, 2021 | 15.64M |
| September 30, 2021 | 40.09M |
| June 30, 2021 | -27.32M |
| March 31, 2021 | -33.46M |
| December 31, 2020 | -4.798M |
| September 30, 2020 | 94.75M |
| June 30, 2020 | 19.36M |
| March 31, 2020 | 50.46M |
| December 31, 2019 | -30.51M |
| September 30, 2019 | 28.27M |
| June 30, 2019 | 36.44M |
| March 31, 2019 | -3.491M |
| December 31, 2018 | 24.99M |
| September 30, 2018 | -222.03M |
| Date | Value |
|---|---|
| June 30, 2018 | -80.91M |
| March 31, 2018 | -102.12M |
| December 31, 2017 | 6.085M |
| September 30, 2017 | -16.89M |
| June 30, 2017 | -0.647M |
| March 31, 2017 | -10.56M |
| December 31, 2016 | 10.08M |
| September 30, 2016 | 11.92M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 14.70M |
| June 30, 2015 | -23.02M |
| March 31, 2015 | 8.317M |
| December 31, 2014 | -0.93M |
| September 30, 2014 | -35.58M |
| June 30, 2014 | 11.48M |
| March 31, 2014 | 16.20M |
| December 31, 2013 | -15.15M |
| September 30, 2013 | 8.493M |
| June 30, 2013 | 18.62M |
| March 31, 2013 | -36.62M |
| December 31, 2012 | 6.52M |
| September 30, 2012 | -6.839M |
| June 30, 2012 | 3.697M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-362.12M
Minimum
Dec 2023
98.05M
Maximum
Mar 2024
-19.90M
Average
17.44M
Median
Cash from Investing (Quarterly) Benchmarks
| ADMA Biologics Inc | -1.098M |
| 89bio Inc | -8.639M |
| Corcept Therapeutics Inc | -44.04M |
| Sarepta Therapeutics Inc | -128.82M |
| Matinas BioPharma Holdings Inc | -2.938M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -66.98M |
| Cash from Financing (Quarterly) | 7.462M |
| Free Cash Flow | -438.32M |
| Free Cash Flow Per Share (Quarterly) | -3.116 |
| Free Cash Flow to Equity (Quarterly) | -68.24M |
| Free Cash Flow Yield | -6.99% |